rs3136435
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000506.5(F2):c.316+36G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0833 in 1,612,902 control chromosomes in the GnomAD database, including 8,822 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.15 ( 2948 hom., cov: 32)
Exomes 𝑓: 0.077 ( 5874 hom. )
Consequence
F2
NM_000506.5 intron
NM_000506.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0760
Publications
13 publications found
Genes affected
F2 (HGNC:3535): (coagulation factor II, thrombin) This gene encodes the prothrombin protein (also known as coagulation factor II). This protein is proteolytically cleaved in multiple steps to form the activated serine protease thrombin. The activated thrombin enzyme plays an important role in thrombosis and hemostasis by converting fibrinogen to fibrin during blood clot formation, by stimulating platelet aggregation, and by activating additional coagulation factors. Thrombin also plays a role in cell proliferation, tissue repair, and angiogenesis as well as maintaining vascular integrity during development and postnatal life. Peptides derived from the C-terminus of this protein have antimicrobial activity against E. coli and P. aeruginosa. Mutations in this gene lead to various forms of thrombosis and dysprothrombinemia. Rapid increases in cytokine levels following coronavirus infections can dysregulate the coagulation cascade and produce thrombosis, compromised blood supply, and organ failure. [provided by RefSeq, May 2020]
F2 Gene-Disease associations (from GenCC):
- thrombophilia due to thrombin defectInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
- congenital prothrombin deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 11-46720876-G-A is Benign according to our data. Variant chr11-46720876-G-A is described in ClinVar as Benign. ClinVar VariationId is 1290658.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.351 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| F2 | ENST00000311907.10 | c.316+36G>A | intron_variant | Intron 4 of 13 | 1 | NM_000506.5 | ENSP00000308541.5 | |||
| F2 | ENST00000530231.5 | c.316+36G>A | intron_variant | Intron 4 of 13 | 5 | ENSP00000433907.1 | ||||
| F2 | ENST00000442468.1 | c.286+36G>A | intron_variant | Intron 4 of 7 | 3 | ENSP00000387413.1 |
Frequencies
GnomAD3 genomes AF: 0.148 AC: 22541AN: 151996Hom.: 2937 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
22541
AN:
151996
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0842 AC: 21029AN: 249896 AF XY: 0.0789 show subpopulations
GnomAD2 exomes
AF:
AC:
21029
AN:
249896
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0765 AC: 111787AN: 1460788Hom.: 5874 Cov.: 31 AF XY: 0.0752 AC XY: 54668AN XY: 726662 show subpopulations
GnomAD4 exome
AF:
AC:
111787
AN:
1460788
Hom.:
Cov.:
31
AF XY:
AC XY:
54668
AN XY:
726662
show subpopulations
African (AFR)
AF:
AC:
12351
AN:
33468
American (AMR)
AF:
AC:
2134
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
1736
AN:
26128
East Asian (EAS)
AF:
AC:
3453
AN:
39694
South Asian (SAS)
AF:
AC:
5628
AN:
86244
European-Finnish (FIN)
AF:
AC:
2469
AN:
52920
Middle Eastern (MID)
AF:
AC:
533
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
78111
AN:
1111464
Other (OTH)
AF:
AC:
5372
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
5525
11050
16574
22099
27624
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3080
6160
9240
12320
15400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.148 AC: 22582AN: 152114Hom.: 2948 Cov.: 32 AF XY: 0.145 AC XY: 10799AN XY: 74376 show subpopulations
GnomAD4 genome
AF:
AC:
22582
AN:
152114
Hom.:
Cov.:
32
AF XY:
AC XY:
10799
AN XY:
74376
show subpopulations
African (AFR)
AF:
AC:
14758
AN:
41434
American (AMR)
AF:
AC:
1173
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
230
AN:
3466
East Asian (EAS)
AF:
AC:
523
AN:
5172
South Asian (SAS)
AF:
AC:
268
AN:
4830
European-Finnish (FIN)
AF:
AC:
502
AN:
10608
Middle Eastern (MID)
AF:
AC:
34
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4731
AN:
68006
Other (OTH)
AF:
AC:
276
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
841
1682
2522
3363
4204
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
226
452
678
904
1130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
352
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.